Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milton

Showing results (251-260 of 11,966) with videos related to

Pageof 1,197
Sort By:
European Journal of Heart Failure|March 23, 2018
Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medicationsMilton Packer
European Journal of Heart Failure|December 19, 2018
The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal rangeMilton Packer
International Journal of Cardiology|March 18, 2018
Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparatorsMilton Packer
Diabetes Care|February 22, 2020
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of ActionMilton Packer
Journal of the American Heart Association|August 14, 2020
Molecular, Cellular, and Clinical Evidence That Sodium-Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart FailureMilton Packer
European Journal of Heart Failure|April 4, 2023
A reclassification of heart failure based on recognition of heart failure with normal to supernormal ejection fraction, a clinically common form of cardiac contracture, with distinctive pathophysiological and therapeutic featuresMilton Packer
Psychiatry|January 20, 2009
A model for interpretative supportive dynamic psychotherapyMilton Viederman
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 27, 2025
Books: <i>What Do I Say Next? Everyday Mental Health Conversations in Primary Care: A Practical Guide</i>: Time well spentHannah Milton
Journal of the American Society of Nephrology : JASN|June 21, 2023
Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKDMilton Packer
Circulation. Heart Failure|September 8, 2020
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) InhibitorsMilton Packer
Pageof 1,197

Showing results (251-260 of 11,966) with videos related to

Sort By:
Pageof 1,197
European Journal of Heart Failure|March 23, 2018
Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medicationsMilton Packer
European Journal of Heart Failure|December 19, 2018
The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal rangeMilton Packer
International Journal of Cardiology|March 18, 2018
Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparatorsMilton Packer
Diabetes Care|February 22, 2020
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of ActionMilton Packer
Journal of the American Heart Association|August 14, 2020
Molecular, Cellular, and Clinical Evidence That Sodium-Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart FailureMilton Packer
European Journal of Heart Failure|April 4, 2023
A reclassification of heart failure based on recognition of heart failure with normal to supernormal ejection fraction, a clinically common form of cardiac contracture, with distinctive pathophysiological and therapeutic featuresMilton Packer
Psychiatry|January 20, 2009
A model for interpretative supportive dynamic psychotherapyMilton Viederman
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 27, 2025
Books: <i>What Do I Say Next? Everyday Mental Health Conversations in Primary Care: A Practical Guide</i>: Time well spentHannah Milton
Journal of the American Society of Nephrology : JASN|June 21, 2023
Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKDMilton Packer
Circulation. Heart Failure|September 8, 2020
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) InhibitorsMilton Packer
Pageof 1,197